Cargando…
Left ventricular hypertrophy in experimental chronic kidney disease is associated with reduced expression of cardiac Kruppel-like factor 15
BACKGROUND: Left ventricular hypertrophy (LVH) increases the risk of death in chronic kidney disease (CKD). The transcription factor Kruppel-like factor 15 (KLF15) is expressed in the heart and regulates cardiac remodelling through inhibition of hypertrophy and fibrosis. It is unknown if KLF15 expre...
Autores principales: | Patel, Sheila K., Velkoska, Elena, Gayed, Daniel, Ramchand, Jay, Lesmana, Jessica, Burrell, Louise M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029153/ https://www.ncbi.nlm.nih.gov/pubmed/29970016 http://dx.doi.org/10.1186/s12882-018-0955-9 |
Ejemplares similares
-
Kruppel-Like Factor 15 Is Critical for the Development of Left Ventricular Hypertrophy
por: Patel, Sheila K., et al.
Publicado: (2018) -
Genetic Variation in Kruppel like Factor 15 Is Associated with Left Ventricular Hypertrophy in Patients with Type 2 Diabetes: Discovery and Replication Cohorts
por: Patel, Sheila K., et al.
Publicado: (2017) -
Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition
por: Burrell, Louise M., et al.
Publicado: (2017) -
Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease
por: Velkoska, Elena, et al.
Publicado: (2016) -
Does Krüppel Like Factor 15 Play an Important Role in the Left Ventricular Hypertrophy of Patients with Type 2 Diabetes?
por: Zhao, Yuguang, et al.
Publicado: (2017)